These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 24755259

  • 1. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.
    Gandhi A, Jana S, Sen KK.
    Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV, Sonavane GS.
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [Abstract] [Full Text] [Related]

  • 4. Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate.
    Hasan AA, Sabry SA, Abdallah MH, El-Damasy DA.
    Pharm Dev Technol; 2016 Sep; 21(6):655-63. PubMed ID: 25915180
    [Abstract] [Full Text] [Related]

  • 5. Preparation and characterization of metformin hydrochloride loaded-Eudragit®RSPO and Eudragit®RSPO/PLGA nanoparticles.
    Cetin M, Atila A, Sahin S, Vural I.
    Pharm Dev Technol; 2013 Sep; 18(3):570-6. PubMed ID: 21864098
    [Abstract] [Full Text] [Related]

  • 6. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y, Wu X, Meng L, Zhang Y, Ai R, Qi N, He H, Xu H, Tang X.
    Int J Pharm; 2012 Oct 15; 436(1-2):341-50. PubMed ID: 22766443
    [Abstract] [Full Text] [Related]

  • 7. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P, Gupta RN, Jha AK, Pandey R.
    Drug Deliv; 2013 Oct 15; 20(7):269-76. PubMed ID: 24044644
    [Abstract] [Full Text] [Related]

  • 8. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
    Sahle FF, Balzus B, Gerecke C, Kleuser B, Bodmeier R.
    Eur J Pharm Sci; 2016 Sep 20; 92():98-109. PubMed ID: 27393341
    [Abstract] [Full Text] [Related]

  • 9. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab, Ahuja A, Khar RK, Baboota S, Chuttani K, Mishra AK, Ali J.
    Drug Deliv; 2011 May 20; 18(4):255-64. PubMed ID: 21110695
    [Abstract] [Full Text] [Related]

  • 10. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
    Sahoo J, Murthy PN, Biswal S, Manik.
    AAPS PharmSciTech; 2009 May 20; 10(1):27-33. PubMed ID: 19145487
    [Abstract] [Full Text] [Related]

  • 11. Floating properties and release characteristics of hollow microspheres of acyclovir.
    Junyaprasert VB, Pornsuwannapha S.
    Drug Deliv; 2008 Jun 20; 15(5):331-41. PubMed ID: 18763164
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100.
    Jana U, Mohanty AK, Manna PK, Mohanta GP.
    Colloids Surf B Biointerfaces; 2014 Jan 01; 113():269-75. PubMed ID: 24140793
    [Abstract] [Full Text] [Related]

  • 13. Exploration of statistical experimental design to improve entrapment efficiency of acyclovir in poly (d, l) lactide nanoparticles.
    Patel PJ, Gohel MC, Acharya SR.
    Pharm Dev Technol; 2014 Mar 01; 19(2):200-12. PubMed ID: 23432525
    [Abstract] [Full Text] [Related]

  • 14. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
    Pandey S, Vijayendra Swamy SM, Ubaid Ulla UM, Gupta A, Patel H, Yadav JS.
    Curr Drug Deliv; 2017 Sep 06; 14(6):887-899. PubMed ID: 27538461
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery.
    Jana S, Maji N, Nayak AK, Sen KK, Basu SK.
    Carbohydr Polym; 2013 Oct 15; 98(1):870-6. PubMed ID: 23987423
    [Abstract] [Full Text] [Related]

  • 17. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
    Seyfoddin A, Al-Kassas R.
    Drug Dev Ind Pharm; 2013 Apr 15; 39(4):508-19. PubMed ID: 22424312
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heterogeneous polymer composite nanoparticles loaded in situ gel for controlled release intra-vaginal therapy of genital herpes.
    Ramyadevi D, Rajan KS, Vedhahari BN, Ruckmani K, Subramanian N.
    Colloids Surf B Biointerfaces; 2016 Oct 01; 146():260-70. PubMed ID: 27351137
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.